Genesis Innovation Group launches $10m Cultivate(MD) medtech venture fund

Genesis Innovation Group said today it formed the Cultivate(MD) Capital Fund, which looks to manage $10 million to invest in early stage healthcare companies with a focus on medical device and orthopedic technologies. Holland, Mich.-based Genesis said it expects the Cultivate(MD) fund to be fully operational and seeking companies to invest in by early 2018. The company said the fund will continue its focus on investing in early stage medtech companies and expand into mid to later-stage companies and investment opportunitites. “Health care is a dynamic space, and inventors and entrepreneurs face significant risk during their development stages, cultivate(MD) brings the necessary capital and access to an experienced team that will guide an innovation to market. In addition to financial capital, innovators need a network of intellectual capital that will help convert their ideas and assumptions into marketable innovations. Genesis provides a nurturing environment for health care innovations,” Genesis Innovation Group CEO & Cultivate(MD) fund manager Rob Ball said in a press release. “We derive our success through the intersection of improved outcomes, cost savings, experienced teams and strong brands, Cultivate(MD)’s unique partnership with Genesis Innovation Group provides for a rich and tangible participation, and a capital-efficient process, that delivers true innovation in market.” The newly formed fund will look to invest in technologies with ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Wall Street Beat genesisinnovationgroup Source Type: news